Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Cytiva | | | | 31.4 | | | | |
| Other | | | | 238.8 | | | | |
| Total revenues [+] | 801.5 | 670.5 | 366.3 | 270.2 | 194.0 | 141.2 | 104.5 | 83.5 |
| Products | | | | | | | | 83.5 |
| Revenue growth | 19.5% | 83.1% | 35.5% | 39.3% | 37.4% | 35.1% | 25.1% | 31.5% |
| Cost of goods sold | 345.8 | 279.3 | 156.6 | 119.1 | 86.5 | 67.1 | 47.1 | 35.3 |
| Gross profit | 455.7 | 391.3 | 209.6 | 151.1 | 107.5 | 74.2 | 57.4 | 48.3 |
| Gross margin | 56.9% | 58.3% | 57.2% | 55.9% | 55.4% | 52.5% | 54.9% | 57.8% |
| Selling, general and administrative | 215.8 | 183.9 | 119.6 | 95.6 | 65.7 | 51.5 | 30.9 | 24.7 |
| Research and development | 43.9 | 34.3 | 20.2 | 19.5 | 15.8 | 8.7 | 7.4 | 5.7 |
| Other operating expenses | -28.7 | 5.9 | | | | | | |
| EBITDA [+] | 275.7 | 205.7 | 96.9 | 57.0 | 41.8 | 24.5 | 24.6 | 22.4 |
| EBITDA growth | 34.0% | 112.3% | 70.1% | 36.4% | 70.4% | -0.2% | 9.4% | 52.5% |
| EBITDA margin | 34.4% | 30.7% | 26.5% | 21.1% | 21.5% | 17.4% | 23.5% | 26.9% |
| Depreciation | 23.9 | 16.3 | 11.0 | 7.3 | 5.2 | 4.3 | 3.2 | 3.0 |
| EBITA | 251.8 | 189.3 | 85.9 | 49.7 | 36.6 | 20.2 | 21.3 | 19.4 |
| EBITA margin | 31.4% | 28.2% | 23.5% | 18.4% | 18.9% | 14.3% | 20.4% | 23.3% |
| Amortization of intangibles | 27.1 | 22.1 | 16.1 | 13.6 | 10.6 | 6.2 | 2.1 | 1.6 |
| EBIT [+] | 224.7 | 167.2 | 69.8 | 36.1 | 26.0 | 14.0 | 19.2 | 17.8 |
| EBIT growth | 34.3% | 139.5% | 93.5% | 38.8% | 85.6% | -27.1% | 7.7% | 66.9% |
| EBIT margin | 28.0% | 24.9% | 19.1% | 13.4% | 13.4% | 9.9% | 18.4% | 21.4% |
| Non-recurring items [+] | | | | | | | 3.2 | 4.1 |
| Loss on contingent liability | | | | | | | 3.2 | 4.1 |
| Interest expense, net [+] | -5.8 | 11.1 | 9.0 | 4.0 | 4.8 | 6.1 | 3.4 | -0.1 |
| Interest expense | 1.2 | 11.3 | 10.8 | 9.3 | 6.7 | 6.4 | 3.8 | 0.0 |
| Interest income | 7.0 | 0.2 | 1.7 | 5.3 | 1.9 | 0.4 | 0.3 | 0.1 |
| Other income (expense), net [+] | -11.3 | -2.6 | -1.6 | -6.0 | 0.3 | -0.7 | -0.9 | -0.4 |
| Gain (loss) on debt retirement | | | | -11.4 | | | | |
| Other | -9.5 | -1.2 | -0.2 | -0.3 | 0.3 | -0.7 | -0.9 | -0.4 |
| Pre-tax income | 219.1 | 153.5 | 59.2 | 26.2 | 21.4 | 7.2 | 11.7 | 13.4 |
| Income taxes | 33.2 | 25.3 | -0.7 | 4.7 | 4.8 | -21.1 | 0.0 | 4.1 |
| Tax rate | 15.1% | 16.4% | | 18.1% | 22.5% | | 0.1% | 30.4% |
| Net income | 186.0 | 128.3 | 59.9 | 21.4 | 16.6 | 28.4 | 11.7 | 9.3 |
| Net margin | 23.2% | 19.1% | 16.4% | 7.9% | 8.6% | 20.1% | 11.2% | 11.2% |
| |
| Basic EPS [+] | $3.35 | $2.33 | $1.14 | $0.44 | $0.38 | $0.74 | $0.35 | $0.28 |
| Growth | 43.8% | 104.5% | 157.5% | 16.7% | -48.8% | 113.1% | 22.4% | 13.0% |
| Diluted EPS [+] | $3.24 | $2.24 | $1.11 | $0.44 | $0.37 | $0.72 | $0.34 | $0.28 |
| Growth | 44.5% | 101.5% | 155.5% | 19.1% | -49.5% | 111.4% | 23.1% | 13.3% |
| |
| Shares outstanding (basic) [+] | 55.5 | 55.0 | 52.6 | 48.3 | 43.8 | 38.2 | 33.6 | 32.9 |
| Growth | 0.8% | 4.7% | 8.7% | 10.5% | 14.5% | 13.9% | 2.1% | 1.2% |
| Shares outstanding (diluted) [+] | 57.5 | 57.3 | 53.9 | 49.2 | 45.5 | 39.2 | 34.1 | 33.6 |
| Growth | 0.3% | 6.3% | 9.5% | 8.2% | 16.1% | 14.8% | 1.6% | 0.9% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|